Dry Eye Syndrome – Current and Future Players

Pages: 84 Published: March 01, 2013 Report Code: GDHC1049FPR

  • Overview
  • Contents
  • Tables
  • Figures
  • Listen
    Powered by iSpeech

GlobalData has released its pharma report, “Dry Eye Syndrome – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Dry Eye Syndrome Market. The report identifies and analyses the key companies shaping and driving the global Dry Eye Syndrome market. The report provides insight into the competitive Dry Eye Syndrome landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts. *This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.


Investigation of current and future market competition for Dry Eye Syndrome

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of Dry Eye Syndrome sector through market impact analysis, future market scenario and company analysis

Reasons to Buy

Gain a high level view of the trends shaping and driving Dry Eye Syndrome market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What’s the next big thing in the global Dry Eye Syndrome market landscape? Identify, understand and capitalize

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures


2.1Related Reports

3Market Outlook

3.1Global Markets


3.1.2Drivers and Barriers – Global Issues

4Current and Future Players


4.2Trends in Corporate Strategy

4.3Company Profiles














5.4Forecasting Methodology

5.4.1Diagnosed DES Patients

5.4.2Percent Drug-Treated Patients

5.4.3Launch Dates

5.4.4General Pricing Assumptions

5.4.5Individual Drug Assumptions

5.4.6Pricing of Pipeline Agents

5.5Primary Research – KOLs Interviewed for this Report

5.6Primary Research – High-prescriber Survey

5.7About the Authors


5.7.2Therapy Area Director


5.7.4Global Head of Healthcare

5.8About GlobalData


List of Tables

Table 1: Global Sales Forecast ($m) for DES Therapies, 2014–2024

Table 2: DES Market – Drivers and Barriers, 2014–2024

Table 3: Key Companies in the Dry Eye Syndrome Market in the 9MM, 2014

Table 4: Allergan’s DES Portfolio Assessment, 2015

Table 5: Herantis’s DES Portfolio Assessment, 2015

Table 6: Mimetogen’s DES Portfolio Assessment, 2015

Table 7: Mitotech’s DES Portfolio Assessment, 2015

Table 8: Otsuka’s DES Portfolio Assessment, 2015

Table 9: RegeneRx’s DES Portfolio Assessment, 2015

Table 10: Santen’s DES Portfolio Assessment, 2015

Table 11: Shire’s DES Portfolio Assessment, 2015

Table 12: Key Launch Dates

Table 13: Surveyed High-prescribing Physicians, by Country

List of Figures

Figure 1: Global Sales for DES Therapies by Region, 2014 and 2024

Figure 2: Global Sales by Region for DES Therapies, 2014–2024

Figure 3: Global Sales for DES by Drug, 2014 and 2024

Figure 4: Global Sales by Drug for DES Therapies, 2014–2024

Figure 5: Company Portfolio Gap Analysis in Dry Eye Syndrome, 2014–2024


Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.